DOCSLIB.ORG

Morgan Stanley Capital I Trust 2021-L5 Form FWP

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Morgan Stanley Capital I Trust 2021-L5 Form FWP SECURITIES AND EXCHANGE COMMISSION FORM FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Filing Date: 2021-04-26 SEC Accession No. 0001539497-21-000554 (HTML Version on secdatabase.com) SUBJECT COMPANY Morgan Stanley Capital I Trust 2021-L5 Mailing Address Business Address 1585 BROADWAY 1585 BROADWAY CIK:1856967| State of Incorp.:DE NEW YORK NY 10036 NEW YORK NY 10036 Type: FWP | Act: 34 | File No.: 333-227446-14 | Film No.: 21854129 212-761-4000 SIC: 6189 Asset-backed securities FILED BY Morgan Stanley Capital I Inc. Mailing Address Business Address 1585 BROADWAY 1585 BROADWAY CIK:1547361| IRS No.: 133291626 | State of Incorp.:DE NEW YORK NY 10036 NEW YORK NY 10036 Type: FWP 212-761-4000 SIC: 6189 Asset-backed securities Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document FREE WRITING PROSPECTUS FILED PURSUANT TO RULE 433 REGISTRATION FILE NO.: 333-227446-14 MSC 2021-L5 Free Writing Prospectus Structural and Collateral Term Sheet $817,058,743 (Approximate Total Mortgage Pool Balance) $719,011,000 (Approximate Offered Certificates) Morgan Stanley Capital I Inc. as Depositor Starwood Mortgage Capital LLC KeyBank National Association Morgan Stanley Mortgage Capital Holdings LLC Argentic Real Estate Finance LLC Barclays Capital Real Estate Inc. as Sponsors and Mortgage Loan Sellers Commercial Mortgage Pass-Through Certificates Series 2021-L5 April 26, 2021 MORGAN STANLEY BARCLAYS KeyBanc Capital Markets Co-Lead Bookrunning Manager Co-Lead Bookrunning Manager Co-Lead Bookrunning Manager Siebert Williams Shank AmeriVet Securities Co-Manager Co-Manager STATEMENT REGARDING THIS FREE WRITING PROSPECTUS Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document The depositor has filed a registration statement (including a prospectus) with the SEC (File No. 333-227446) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the depositor has filed with the SEC for more complete information about the depositor, the issuing entity and this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the depositor or any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll free 1-866-718-1649 or by email to [email protected]. This is not a research report and was not prepared by any Underwriter’s research department. It was prepared by the Underwriters’ sales, trading, banking or other non-research personnel. Please see additional important information and qualifications at the end of this Term Sheet. Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document MSC 2021-L5 Neither this Term Sheet nor anything contained herein shall form the basis for any contract or commitment whatsoever. The information contained herein is preliminary as of the date hereof. This Term Sheet is subject to change, completion or amendment from time to time. The information contained herein supersedes information in any other communication relating to the securities described herein; provided, that the information contained herein will be superseded by similar information delivered to you as part of the Preliminary Prospectus. The information contained herein should be reviewed only in conjunction with the entire Preliminary Prospectus. All of the information contained herein is subject to the same limitations and qualifications contained in the Preliminary Prospectus. The information contained herein does not contain all relevant information relating to the underlying mortgage loans or mortgaged properties. Such information is described in the Preliminary Prospectus. The information contained herein will be more fully described in the Preliminary Prospectus. The information contained herein should not be viewed as projections, forecasts, predictions or opinions with respect to value. Prior to making any investment decision, prospective investors are strongly urged to read the Preliminary Prospectus in its entirety. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this Term Sheet is truthful or complete. Any representation to the contrary is a criminal offense. IMPORTANT NOTICE RELATING TO AUTOMATICALLY GENERATED EMAIL DISCLAIMERS Any legends, disclaimers or other notices that may appear at the bottom of, or attached to, the email communication to which this Term Sheet may have been attached are not applicable to this Term Sheet and should be disregarded. Such legends, disclaimers or other notices have been automatically generated as a result of this Term Sheet having been sent via Bloomberg or another email system. IMPORTANT NOTICE REGARDING THE CONDITIONS FOR THIS OFFERING OF ASSET-BACKED SECURITIES THE ASSET-BACKED SECURITIES REFERRED TO IN THIS TERM SHEET ARE BEING OFFERED WHEN, AS AND IF ISSUED. IN PARTICULAR, YOU ARE ADVISED THAT THE ASSET-BACKED SECURITIES, AND THE ASSET POOL BACKING THEM, ARE SUBJECT TO MODIFICATION OR REVISION (INCLUDING, AMONG OTHER THINGS, THE POSSIBILITY THAT ONE OR MORE CLASSES OF SECURITIES MAY BE SPLIT, COMBINED OR ELIMINATED), AT ANY TIME PRIOR TO ISSUANCE OR AVAILABILITY OF A FINAL PROSPECTUS. AS A RESULT, YOU MAY COMMIT TO PURCHASE SECURITIES THAT HAVE CHARACTERISTICS THAT MAY CHANGE, AND YOU ARE ADVISED THAT ALL OR A PORTION OF THE SECURITIES MAY NOT BE ISSUED THAT HAVE THE CHARACTERISTICS DESCRIBED IN THIS TERM SHEET. OUR OBLIGATION TO SELL SECURITIES TO YOU IS CONDITIONED ON THE SECURITIES AND THE UNDERLYING TRANSACTION HAVING THE CHARACTERISTICS DESCRIBED IN THIS TERM SHEET. IF WE DETERMINE THAT THE FOREGOING CONDITION IS NOT SATISFIED IN ANY MATERIAL RESPECT, WE WILL NOTIFY YOU, AND NEITHER THE ISSUING ENTITY NOR ANY UNDERWRITER WILL HAVE ANY OBLIGATION TO YOU TO DELIVER ALL OR ANY PORTION OF THE SECURITIES WHICH YOU HAVE COMMITTED TO PURCHASE, AND THERE WILL BE NO LIABILITY BETWEEN US AS A CONSEQUENCE OF THE NON-DELIVERY. This is not a research report and was not prepared by any Underwriter’s research department. Please see additional important information and qualifications at the end of this Term Sheet. T-2 Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document MSC 2021-L5 Structural Overview Offered Certificates Approximate Approximate Approximate Expected Initial Initial Expected Certificate Initial Expected Certificate Ratings Available Retained Approximate Pass- Weighted Principal Certificate Through Principal Principal Class (Fitch/ Certificate Certificate Initial Credit Average UW NOI Balance or Rate Window to Value KBRA/ Balance or Balance or Support(4) Life Debt Notional Description (Months)(5) Ratio(7) S&P)(1) Notional Notional (Years)(5) Yield(6) Amount(2) Amount(2)(3) Amount(2)(3) AAAsf/ AAA(sf)/ 30.000% 3.01 1 – 59 Class A-1 AAA(sf) $10,000,000 $9,572,000 $428,000 (8) 14.9% 39.1% AAAsf/ 14.9% AAA(sf)/ 30.000% 4.94 59 – 60 Class A-2 AAA(sf) $68,700,000 $65,759,000 $2,941,000 (8) 39.1% AAAsf/ 30.000% 14.9% 39.1% Class A- AAA(sf)/ 7.52 60 – 115 SB AAA(sf) $23,644,000 $22,632,000 $1,012,000 (8) AAAsf/ 30.000% 14.9% 39.1% Class AAA(sf)/ A-3(9) AAA(sf) (9)(10) (9)(10) (9)(10) (8)(9) (10) (10) AAAsf/ 30.000% 14.9% 39.1% Class AAA(sf)/ A-4(9) AAA(sf) (9)(10) (9)(10) (9)(10) (8)(9) (10) (10) AAAsf/ AAA(sf)/ Class X-A AAA(sf) $571,941,000(11) $547,461,000(11) $24,480,000(11) N/A Variable(12) N/A N/A N/A N/A A-sf/ AAA(sf)/ Class X-B A-(sf) $147,070,000(11) $140,775,000(11) $6,295,000(11) N/A Variable(12) N/A N/A N/A N/A AAAsf/ 21.250% 9.93 119 – 13.2% 43.9% Class A- AAA(sf)/ 119 S(9) AAA(sf) $71,492,000(9) $68,432,000(9) $3,060,000(9) (8)(9) AA-sf/AA- 16.375% 9.93 119 – 12.4% 46.7% (sf)/AA- 119 Class B(9) (sf) $39,832,000(9) $38,127,000(9) $1,705,000(9) (8)(9) A-sf/A- 12.000% 9.97 119 – 11.8% 49.1% Class C(9) (sf)/A-(sf) $35,746,000(9) $34,216,000(9) $1,530,000(9) (8)(9) 120 Privately Offered Certificates(13) Approximate Approximate Approximate Pass- Expected Approximate Expected Certificate Initial Initial Initial Through Expected Certificate Class Ratings Initial Credit Weighted Principal Certificate Available Retained Rate Principal Principal (Fitch/ (4) Average UW NOI Balance or Certificate Certificate Support Description Copyright © 2021 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Balance or Balance or KBRA/ Notional Life Window Debt to Value Notional Notional S&P)(1) Amount(2) (Years)(5) (Months)(5) Yield(6) Ratio(7) Amount(2)(3) Amount(2)(3) BBB-sf/ Class X- BBB-(sf)/ (11) (11) (11) N/A (12) N/A N/A N/A N/A D $39,832,000 $38,126,000 $1,706,000 Variable NR Class X- BB-sf/BB- F (sf)/NR $19,405,000(11) $18,574,000(11) $831,000(11) N/A Variable(12) N/A N/A N/A N/A Class X- B-sf/B- G (sf)/NR $8,171,000(11) $7,821,000(11) $350,000(11) N/A Variable(12) N/A N/A N/A N/A BBBsf/ BBB(sf)/ 120 – 120 Class D NR $22,469,000 $21,507,000 $962,000 9.250% (8) 10.01 11.5% 50.6% BBB-sf/ (8) 10.01 120 – 120 11.2% 51.8% BBB-(sf)/ Class E NR $17,363,000 $16,619,000 $744,000 7.125% BB-sf/BB- (8) 10.01 120 – 120 10.9% 53.1% Class F (sf)/NR $19,405,000 $18,574,000 $831,000 4.750% B-sf/B- (8) 10.01 120 – 120 10.8% 53.7% Class G (sf)/NR $8,171,000 $7,821,000 $350,000 3.750% Class H- NR/NR/ (8) 10.01 120 – 120 10.4% 55.8% RR NR $30,639,742 $29,328,361 $1,311,381 0.000% Ratings shown are those of Fitch Ratings, Inc.
Load more

Recommended publications
  • Russell 3000® Weight(%) Country Russell 3000® Weight(%) Country Russell 3000® Weight(%) Country
    FTSE Russell Publications ESMA Compliance Quarterly Membership Weights Russell 3000® Weight(%) Country Russell 3000® Weight(%) Country Russell 3000® Weight(%) Country 1-800 Flowers Com Abiomed Inc Acutus Medical 0.002 United States 0.035 United States 0.000 United States 10x Genomics Abm Industries Inc Adams Resources & Energy 0.026 United States 0.008 United States 0.000 United States 1life Healthcare Acacia Research Corp Adapthealth 0.008 United States 0.001 United States 0.007 United States 1st Constitution Bancorp Academy Sports And Outdo Adaptive Biotechnologies 0.000 United States 0.002 United States 0.008 United States 1st Source Corp Acadia Healthcare Co Addus Homecare Corp 0.002 United States 0.012 United States 0.004 United States 2u Inc Acadia Pharmaceuticals Adient Plc 0.007 United States 0.007 United States 0.010 United States 3d Systems Corp Acadia Realty Trust Adma Biologics Inc 0.008 United States 0.004 United States 0.000 United States 3m Co Accel Entertainment (a) Adobe Inc 0.268 United States 0.001 United States 0.567 United States 4d Molecular Therapeutic Accelerate Diagnostics Adt Inc 0.001 United States 0.001 United States 0.003 United States 89bio Acceleron Pharma Inc Adtalem Global Education 0.000 United States 0.017 United States 0.005 United States 8x8 Inc New Accenture Plc Ireland Adtran Inc 0.009 United States 0.436 United States 0.002 United States 908 Devices Acco Brands Corp Advance Auto Parts Inc 0.001 United States 0.002 United States 0.030 United States A Mark Precious Metals Accolade Advanced Drainage
    [Show full text]
  • The Agenda Diversity 100 Board-Ready, Diverse Candidates You’Ve Never Heard Of
    The Agenda Diversity 100 Board-Ready, Diverse Candidates You’ve Never Heard Of June 2021 A Note to Readers Dear Readers, The past year has seen unprecedented demand for directors from underrepresented communities. Boards have recognized that a full spectrum of voices in leadership is necessary to remain competitive in today’s demanding marketplace (for recent developments, see methodology, pages v and vi). Meanwhile, investors, proxy advisors and regulators are also pushing boards to diversify themselves. Agenda, the Financial Times’ publication for corporate board members, and our partner Equilar are aiming to help our audience meet these demands by offering this list of 100 pre-vetted and board-ready candidates. Each hails from one of the demographic groups identified by California lawmakers in recent legislation aimed at diversifying boardrooms. Previous international and state laws establishing requirements for gender diversity on boards have shown how intentionality in board recruitment can really move the needle — hundreds of companies added women to their boards after laws requiring female directors were passed. Diversifying boards, which have remained largely male and white in the United States, requires deliberate recruitment choices. Meanwhile, our internal data at Agenda shows a keen interest among our readership in finding more board members from diverse backgrounds. Those named on our list of 100 were confirmed by the well-respected board directors and other governance experts on our nominating and selection committees to have the leadership and strategic skills necessary to add value to a board. We encourage you to make use of this directory as you look to diversify your candidate slates.
    [Show full text]
  • FTSE North America All Cap
    2 FTSE Russell Publications 19 August 2021 FTSE North America All Cap Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 10X Genomics 0.04 USA Allakos 0.01 USA Apartment Inv Management <0.005 USA 1Life Healthcare 0.01 USA Alleghany 0.02 USA Apellis Pharmaceuticals 0.01 USA 1st Source <0.005 USA Allegheny Technologies 0.01 USA APi Group 0.01 USA 2U 0.01 USA Allegiant Travel <0.005 USA Apogee Enterprises <0.005 USA 3-D Systems 0.01 USA Allegion PLC 0.03 USA Apollo Commercial Real Estate Finance <0.005 USA 3M Company 0.25 USA Allegro MicroSystems <0.005 USA Apollo Global Management Inc 0.02 USA 8x8 0.01 USA Allete 0.01 USA AppFolio 0.01 USA Aaon Inc 0.01 USA Alliance Data Systems Corp 0.01 USA Appian 0.01 USA AAR Corp <0.005 USA Alliant Energy 0.03 USA Apple Hospitality REIT 0.01 USA Abbott Laboratories 0.44 USA Allied Properties REIT 0.01 CANADA Apple Inc. 4.72 USA AbbVie Inc 0.44 USA Allison Transmission Holdings 0.01 USA Applied Industrial Technology 0.01 USA Abercrombie & Fitch A 0.01 USA Allogene Therapeutics <0.005 USA Applied Materials 0.29 USA Abiomed Inc 0.03 USA AllScripts Healthcare Solutions 0.01 USA Aptargroup 0.02 USA ABM Industries Inc 0.01 USA Allstate Corp 0.09 USA Aptiv PLC 0.09 USA Academy Sports and Outdoors 0.01 USA Ally Financial 0.04 USA Aramark 0.02 USA Acadia Healthcare 0.01 USA Alnylam Pharmaceuticals 0.04 USA Arc Resources 0.01 CANADA Acadia Pharmaceuticals 0.01 USA Alphabet Class A 1.61 USA Arch Capital Gp 0.03 USA Acadia Realty <0.005 USA Alphabet Class C 1.56 USA Archer Daniels Midland 0.07 USA Acceleron Pharma Inc 0.01 USA AltaGas.
    [Show full text]
  • NASDAQ Index
    NASDAQ- Thursday December 31,2020 Symbol Name Last A Agilent Technologies Inc. Common Stock $117.55 AA Alcoa Corporation Common Stock $23.24 AACG ATA Creativity Global American Depositary Shares $1.19 AACQ Artius Acquisition Inc. Class A Common Stock $10.60 AACQU Artius Acquisition Inc. Unit $11.30 AACQW Artius Acquisition Inc Warrant $2.20 AAIC Arlington Asset Investment Corp Class A (new) $3.85 AAIC.PRB Arlington Asset Investment Corp NA AAIC.PRC Arlington Asset Investment Corp NA AAL American Airlines Group Inc. Common Stock $15.88 AAMC Altisource Asset Management Corp Com $23.72 AAME Atlantic American Corporation Common Stock $2.10 AAN Aarons Holdings Company Inc. Common Stock $19.34 AAOI Applied Optoelectronics Inc. Common Stock $8.50 AAON AAON Inc. Common Stock $66.59 AAP Advance Auto Parts Inc Advance Auto Parts Inc W/I $157.02 AAPL Apple Inc. Common Stock $132.76 AAT American Assets Trust Inc. Common Stock $28.51 AAU Almaden Minerals Ltd. Common Shares $0.47 AAWW Atlas Air Worldwide Holdings NEW Common Stock $54.52 AAXN Axon Enterprise Inc. Common Stock $122.84 AB AllianceBernstein Holding L.P. Units $33.68 ABB ABB Ltd Common Stock $27.91 ABBV AbbVie Inc. Common Stock $107.01 ABC AmerisourceBergen Corporation Common Stock $96.81 ABCB Ameris Bancorp Common Stock $38.20 ABCL AbCellera Biologics Inc. Common Shares $39.50 ABCM Abcam plc American Depositary Shares $21.32 ABEO Abeona Therapeutics Inc. Common Stock $1.58 ABEV Ambev S.A. American Depositary Shares (Each representing 1 Common Share)$3.03 ABG Asbury Automotive Group Inc Common Stock $145.39 ABIO ARCA biopharma Inc.
    [Show full text]
  • Russell 3000® Value Weight(%) Country Russell 3000® Value Weight(%) Country Russell 3000® Value Weight(%) Country
    FTSE Russell Publications ESMA Compliance Quarterly Membership Weights Russell 3000® Value Weight(%) Country Russell 3000® Value Weight(%) Country Russell 3000® Value Weight(%) Country 1st Constitution Bancorp Accolade Aeglea Biotherapeutics 0.001 United States 0.001 United States 0.000 United States 1st Source Corp Acelrx Pharmaceuticals Aes Corp 0.004 United States 0.001 United States 0.086 United States 2u Inc Acnb Corp Affiliated Managers Grp 0.009 United States 0.001 United States 0.033 United States 3d Systems Corp Activision Blizzard Inc Aflac Inc 0.016 United States 0.210 United States 0.171 United States 3m Co Acuity Brands Inc Agco Corp 0.180 United States 0.029 United States 0.043 United States 4d Molecular Therapeutic Acushnet Holdings Corp Agile Therapeutics Inc 0.000 United States 0.005 United States 0.000 United States 908 Devices Acutus Medical Agilent Technologies Inc 0.000 United States 0.000 United States 0.173 United States A Mark Precious Metals Adams Resources & Energy Agios Pharmaceuticals 0.001 United States 0.000 United States 0.014 United States Aar Corp Adient Plc Agnc Investment 0.007 United States 0.020 United States 0.044 United States Abbott Laboratories Adma Biologics Inc Agree Realty Corp 0.624 United States 0.000 United States 0.020 United States Abbvie Inc Adt Inc Agrify 0.056 United States 0.006 United States 0.000 United States Abeona Therapeutics Inc Adtalem Global Education Agrofresh Solutions Inc 0.000 United States 0.010 United States 0.000 United States Abercrombie & Fitch Adtran Inc Air Lease
    [Show full text]
  • All World 3000 Index - 19 August 2021
    2 FTSE Russell Publications FTSE RAFI All World 3000 Index - 19 August 2021 QSR Indicative Index Weight Data as at Closing on 30 June 2021 Index Index Index Constituent Country Constituent Country Constituent Country weight (%) weight (%) weight (%) 1&1 AG <0.005 GERMANY AGL Energy 0.01 AUSTRALIA Altra Industrial Motion <0.005 UNITED STATES 3i Group 0.03 UNITED AGNC Investment 0.02 UNITED STATES Altria Group 0.21 UNITED STATES KINGDOM Agnico Eagle Mines 0.01 CANADA Aluminum Corp of China (A) (SC SH) <0.005 CHINA 3M Company 0.16 UNITED STATES Agricultural Bank of China (A) (SC SH) 0.02 CHINA Aluminum Corp of China (H) 0.01 CHINA A P Moller - Maersk A 0.03 DENMARK Agricultural Bank of China (H) 0.05 CHINA Amada 0.01 JAPAN A P Moller - Maersk B 0.04 DENMARK Ahold Delhaize 0.11 NETHERLANDS Amadeus IT Group SA 0.03 SPAIN A2A 0.01 ITALY AIA Group Ltd. 0.15 HONG KONG Amazon.Com 0.34 UNITED STATES AAC Technologies Holdings 0.01 HONG KONG AIB Group PLC 0.01 IRELAND Ambev SA 0.04 BRAZIL AAK <0.005 SWEDEN Air Canada Cl B 0.02 CANADA AMC Networks 0.01 UNITED STATES Aalberts NV 0.01 NETHERLANDS Air China (A) (SC SH) <0.005 CHINA Amcor CDI 0.03 AUSTRALIA Aareal Bank AG 0.01 GERMANY Air China (H) <0.005 CHINA Amdocs 0.01 UNITED STATES ABB 0.1 SWITZERLAND Air France-KLM 0.02 FRANCE AMERCO 0.01 UNITED STATES Abbott Laboratories 0.13 UNITED STATES Air Lease 0.01 UNITED STATES Ameren Corp 0.04 UNITED STATES AbbVie Inc 0.2 UNITED STATES Air Liquide 0.1 FRANCE America Movil L 0.05 MEXICO Abercrombie & Fitch A 0.01 UNITED STATES Air Products & Chemicals Inc
    [Show full text]
  • List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee
    1666 K Street NW Washington, DC 20006 Office: (202) 207-9100 www.pcaobus.org List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee Determination of Payment under PCAOB Rule 7104(b) As of September 22, 2021 The following is a list of issuers that have been assessed and have no outstanding past-due share of the issuer accounting support fees of the Public Company Accounting Oversight Board ("PCAOB") and the Financial Accounting Standards Board ("FASB"), as of September 22, 2021.1/ A registered public accounting firm may take the inclusion of an issuer on this list as an indication that the issuer has no outstanding past-due share of the issuer accounting support fee for purposes of PCAOB Rule 7104(b). This list will be updated at least bi-weekly. If a registered public accounting firm cannot obtain a representation from the issuer or cannot determine by reviewing the list below whether the issuer has no past-due share of the accounting support fee outstanding, the registered public accounting firm may contact the staff by phone at 1-202-207-9294 (Business Days: 9:00 a.m. to 5:00 p.m. ET) or by email at [email protected]. If you believe an issuer has been excluded from this list in error, please contact the staff by phone at 1-202-207-9294 (Business Days: 9:00 a.m. to 5:00 p.m. ET) or by email at [email protected]. Additional information about the issuer accounting support fee and the funding process is available in the Frequently Asked Questions ("FAQs") available in the Accounting Support Fee section of the PCAOB's Web site (http://pcaobus.org/About/Administration/SupportFee/Pages/SupportFeeFAQ.aspx).
    [Show full text]
  • Membership List
    Russell US Indexes Membership list Russell 3000® Index Company Ticker Company Ticker 10X GENOMICS TXG ADTRAN INC ADTN 1-800-FLOWERS.COM CL A FLWS ADVANCE AUTO PARTS AAP 1LIFE HEALTHCARE ONEM ADVANCED DRAINAGE SYSTEMS WMS 1ST SOURCE SRCE ADVANCED ENERGY INDUSTRIES AEIS 22ND CENTURY GROUP INC. XXII ADVANCED MICRO DEV AMD 2U TWOU ADVANSIX ASIX 3-D SYSTEMS DDD ADVANTAGE SOLUTIONS INC (A) ADV 3M COMPANY MMM ADVENT TECHNOLOGIES HOLDINGS INC (A) ADN 4D MOLECULAR THERAPEUTICS FDMT ADVERUM BIOTECHNOLOGIES ADVM 89BIO ETNB AECOM ACM 8X8 EGHT AEGLEA BIOTHERAPEUTICS AGLE 9 METERS BIOPHARMA INC NMTR AEMETIS AMTX 908 DEVICES MASS AERIE PHARMACEUTICALS INC AERI A10 NETWORKS ATEN AEROJET ROCKETDYNE HOLDINGS AJRD AAON INC AAON AEROVIRONMENT AVAV AAR CORP AIR AERSALE CORPORATION ASLE ABBOTT LABORATORIES ABT AES CORP. AES ABBVIE INC ABBV AEVA TECHNOLOGIES INC AEVA ABERCROMBIE & FITCH A ANF AFC GAMMA AFCG ABIOMED INC ABMD AFFILIATED MANAGERS GROUP AMG ABM INDUSTRIES INC ABM AFFIMED N.V. AFMD ACACIA RESEARCH - ACACIA TECHNOLOGIES ACTG AFLAC AFL ACADEMY SPORTS AND OUTDOORS ASO AGCO CORP AGCO ACADIA HEALTHCARE ACHC AGEAGLE AERIAL SYSTEMS UAVS ACADIA PHARMACEUTICALS ACAD AGENUS AGEN ACADIA REALTY AKR AGILENT TECHNOLOGIES A ACCEL ENTERTAINMENT (A) ACEL AGILITI AGTI ACCELERATE DIAGNOSTICS AXDX AGILON HEALTH AGL ACCELERON PHARMA INC XLRN AGILYSYS AGYS ACCENTURE CL A ACN AGIOS PHARMACEUTICALS AGIO ACCO BRANDS ACCO AGNC INVESTMENT AGNC ACCOLADE ACCD AGREE REALTY ADC ACCRETIVE HEALTH RCM AIR LEASE AL ACCURAY ARAY AIR PRODUCTS & CHEMICALS INC APD ACI WORLDWIDE ACIW AIR
    [Show full text]